╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Brain tumor and other neoplastic disorders outside │ Brain tumor and other neoplastic disorders outside │
│ the brain where disease itself or its treatment    │ the brain where disease itself or its treatment    │
│ (radiation, chemotherapy) is likely to affect      │ (radiation, chemotherapy) is likely to affect      │
│ brain structure or function                        │ brain structure or function.                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Neurodegenerative disorders (i.e. Parkinson        │ No Match                                           │
│ disease, LBD, or FTD)                              │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Person's participating in other research projects  │ No Match                                           │
│ will be excluded when the other project(s) involve │                                                    │
│ administration of study drug or other experimental │                                                    │
│ therapy                                            │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Male and female subjects between 20-100 years old  │ No Match                                           │
│ will be enrolled                                   │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ All subjects will speak English as their first     │ All subjects will speak English as their first     │
│ language or demonstrate proficiency in English     │ language or demonstrate proficiency in English     │
│                                                    │ (defined as reaching a scaled score of > 11 on the │
│                                                    │ WAIS vocabulary test).                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Anti-depressants with anti-cholinergic properties  │ Anti-depressants with anti-cholinergic properties  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Stroke when meeting criteria for total anterior,   │ Stroke when meeting criteria for total anterior,   │
│ partial anterior or posterior circulation infarct  │ partial anterior or posterior circulation infarct  │
│ according to the Oxford Community Stroke Project   │ according to the Oxford Community Stroke Project   │
│ classification                                     │ classification. Patients with clinically silent of │
│                                                    │ lacunar strokes and transient ischemic attacks     │
│                                                    │ will not be excluded.                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Person's participating in other research projects  │ No Match                                           │
│ will be excluded when the other project(s)         │                                                    │
│ prohibit participation in other research projects  │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Mental retardation                                 │ Mental retardation.                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Long-life DSM-IV axis 1 disorders                  │ Long-life DSM-IV axis 1 disorders.                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Radiation exposures exceeding annual Rad Worker    │ Radiation exposures exceeding annual Rad Worker    │
│ limits                                             │ limits.                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hydrocephalus                                      │ Hydrocephalus.                                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Substance abuse                                    │ Substance abuse.                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Significant head trauma                            │ Significant head trauma.                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Regular use of narcotic analgesics (>2 doses per   │ Regular use of narcotic analgesics (>2 doses per   │
│ week)                                              │ week).                                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Person's receiving chronic anti-coagulation        │ No Match                                           │
│ therapy                                            │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Long life major depression. Baseline scores ≥20 on │ No Match                                           │
│ Beck Depression Inventory at baseline              │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Concurrent medication limiting validity of         │ Concurrent medication limiting validity of         │
│ neuropsychological tests or imaging                │ neuropsychological tests or imaging.               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Heart failure stage D as defined by American Heart │ Heart failure stage D as defined by American Heart │
│ Association                                        │ Association (7).                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Person's participating in other research projects  │ No Match                                           │
│ will be excluded when the other project(s) involve │                                                    │
│ radiation exposure which in combination with the   │                                                    │
│ current project would increase radiation exposure  │                                                    │
│ above federal guidelines                           │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Must have minimum age of 20 Years                  │ No Match                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Monoamine oxidase inhibitors (MAOi)                │ Monoamine oxidase inhibitors (MAOi)                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ All subjects may have normal cognition or          │ No Match                                           │
│ cognitive impairment                               │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Uncontrolled hypertension or metabolic disease     │ Uncontrolled hypertension or metabolic disease     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Use of neuroleptics                                │ Use of neuroleptics                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Must have maximum age of 100 Years                 │ No Match                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hostility or refusal to cooperate                  │ Hostility or refusal to cooperate                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ All subjects will be in good general health and    │ All subjects will be in good general health and    │
│ able to participate in the LP and imaging exams    │ able to participate in the LP and imaging exams.   │
│                                                    │ This determination is made by the study            │
│                                                    │ neurologist and reviewed at a consensus meeting    │
│                                                    │ for each subject.                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Implanted medical devices that are incompatible    │ Implanted medical devices that are incompatible    │
│ with MRI imaging                                   │ with MRI imaging.                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Chronic kidney disease in stages ≥ 4, as defined   │ No Match                                           │
│ per National Kidney Foundation                     │                                                    │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛